Bifidobacteria

Anotusi

• Masalo e aoga mo ...
• Masalo le aoga mo ...
• Le lava molimau e fuaina aoga mo ...
• Lapataiga faʻapitoa & lapataʻiga:

O le Bifidobacteria o se vaega o siama e masani ona ola i totonu o gaʻo. E mafai ona tupu i fafo o le tino ona ave lea e le gutu e fai ma vailaʻau.

O le Bifidobacteria e masani ona faʻaaoga mo le manava tata, manava manava, o le faaletonu o le manava e taʻua o le irritable bowel syndrome, mo le puipuia o le malulu masani poʻo le fulū, ma le tele o isi tulaga, ae e leai se lelei faʻasaienisi faʻamaoniga e lagolagoina le tele o nei faʻaaoga.

Faʻamaʻi Coronavirus 2019 (COVID-19): E leai se faʻamaoniga lelei e lagolago ai le faʻaaogaina o le bifidobacteria mo le COVID-19. Mulimuli i filifiliga soifua maloloina soifua maloloina ma faʻataʻitaʻia le puipuia auala.

Natura Faʻafomaʻi Maea Faʻamatalaga fua faatatau aoga faʻavae i luga o faʻasaienitisi faʻamaoniga e tusa ma le fua faʻatatau lenei: Aoga, Masalo Lelei Lelei, E Lelei Lelei, Masalo Lelei Lelei, Masalo Lelei, Le Lelei, ma Le lava Faʻamaoniga e Fuafua ai.

Le aoga togi mo BIFIDOBACTERIA e faapea:

Masalo e aoga mo ...

• Paneta. Ole tele o suʻesuʻega o loʻo faʻaalia ai o le avea o le bifidobacteria e mafai ai ona faʻateleina le gaioiga o le manava pe a ma le 1.5 nofoa i le vaiaso i tagata e maua i le papala. Ae le o uma ituaiga o bifidobacteria e foliga mai e aoga.
• O faʻamaʻi pipisi o meaʻai e mafai ona taitai atu ai i papala (Helicobacter pylori poʻo le H. pylori). Avea le bifidobacteria ma le lactobacillus faʻatasi ai ma togafitiga masani H. pylori e ono fesoasoani e aveʻese ai faʻamaʻi H. pylori pe tusa ma le faʻalua faʻapea foi ma le faia naʻo le H. pylori togafitiga faʻapitoa. E mafai foi ona faʻaititia aʻafiaga pei o le manava tata ma le tofo leaga mai H. pylori togafitiga.
• O se faʻaletonu taimi o le lapoʻa tele e mafua ai le manava tiga (itaitagofie bowel poʻo IBS). O le tele o suʻesuʻega o loʻo faʻaalia ai o le avea o le bifidobacteria mo le 4-8 vaiaso e mafai ona faʻaititia ai faʻailoga a le IBS e pei o le manava o le manava, fulafula, ma le faigata ona maua o lou manava. E ono faʻaititia ai foʻi faʻailoga pei o le popole ma faʻanoanoaga i tagata e maua i le IBS. Ae le o uma ituaiga o bifidobacteria e foliga mai e aoga.
• O se faʻalavelave pe a uma taotoga mo ulcerative colitis (pouchitis). Avea se tuʻufaʻatasia o bifidobacteria ma lactobacillus, ma pe leai streptococcus, e le gutu foliga mai e fesoasoani puipuia pouchitis ina ua maeʻa taotoga mo ulcerative colitis.
• Siama o auala vaalele. O le tele o suʻesuʻega o loʻo faʻaalia ai o le faʻaaogaina o vailaʻau faʻapitoa e iai le bifidobacteria e fesoasoani e puipuia ai faʻamaʻi pipisi o le ea e pei o le maalili masani i isi tagata soifua maloloina, e aofia ai tamaiti aʻoga ma tamaiti aʻoga o le kolisi Ae o le avea o le bifidobacteria e foliga mai e le faʻaititia ai le aʻafia o faʻamaʻi pipisi i ala o le ea i tamaiti ma tamaiti talavou i falemaʻi poʻo tagata matutua o loʻo vaʻaia.
• O le manava tata e mafua mai i le rotavirus. O le tuʻuina atu o le bifidobacteria i pepe ua maua i le manava rotaviral e mafai ona faʻapuʻupuʻu le umi o le manava tata pe tusa ma le tasi le aso.
• Malu o le tagata malaga. O le aveina o le bifidobacteria e fesoasoani e puipuia ai le manava o tagata femalagaaʻi pe a faʻaaogaina ma isi probiotics pei o lactobacillus poʻo le streptococcus.
• O se ituaiga o faʻamaʻi manava manava (ulcerative colitis). Suʻesuʻega faʻaalia ai o le faʻaaogaina o probiotics o loʻo iai le bifidobacteria faʻatasi ai ma le lactobacillus ma le streptococcus e mafai ona fesoasoani e faʻatele ai le remission rate e toeititi 2-lafu i tagata e maua i le ulcerative colitis. Peitaʻi, o le tele o suʻesuʻega faʻaalia ai o le bifidobacteria e le aoga mo le puipuia o le toe solomuli.

Masalo le aoga mo ...

• Faʻaleaʻoga i mea e manatua ma mafaufauga e masani ona tupu i le matua. Bifidobacteria e foliga mai e le faʻaleleia atili le mafaufau ma le manatuaina o tomai i tagata matutua ma le pa'ū masani i mafaufauga mafaufauga.
• Siama o le gastrointestinal tract e siama valaʻauina Clostridium difficile. O le tele o suʻesuʻega faʻaalia ai o le aveina o bifidobacteria faʻatasi ai ma isi togafiti faʻataʻitaʻi e le puipuia ai le manava tata e mafua mai i le faʻamaʻi pipisi o Clostridium.
• Atinaʻe pepe. O le tuʻuina atu o le fua e aofia ai le bifidobacteria ma le lactobacillus e le faʻaleleia ai le tuputupu aʻe o pepe.
• Puta tele. O le tele o suʻesuʻega o loʻo faʻaalia ai o le avea o le bifidobacteria e oʻo atu i le 6 masina e le faʻaleleia ai le paʻu o pauna i tagata ua ova poʻo ua ova le puputa.
• Toto pipisi (sepsis). O le faʻaopoopoina o le bifidobacteria i tamaʻi tama fua e le puipuia ai sepsis i pepe vave fanau.

Le lava molimau e fuaina aoga mo ...

• O le manava tatā i tagata o loʻo inu vailaʻau faʻafomaʻi (antibiotic-associate diarrhea). Ua faʻaalia mai i suʻesuʻega le aveina o bifidobacteria faʻatasi ai ma vailaʻau faʻafomaʻi e mafai ona faʻaititia ai le avanoa o le manava tata e tusa ma le 45%. Ae e iai feteʻenaʻiga o loʻo iai. E ono mafai e le bifidobacteria ona puipuia le manava tata e mafua mai i nisi fualaʻau ae le o isi. Faʻapea foi, bifidobacteria ono galue sili atu pe a faʻaaogaina i nisi tuʻufaʻatasiga ma lactobacillus ma streptococcus. Ae le o faʻatasiga uma e foliga mai e aoga.
• Taʻalo afeleti. I le amataga o suʻesuʻega, o le faʻaaogaina o le bifidobacteria e fesoasoani ai i tagata aʻoga ua aʻoaʻoina e tamoʻe atili i le taimi tutusa.
• Eczema (atopic dermatitis). O nisi suʻesuʻega faʻaalia ai o le tuʻuina atu o le bifidobacterium i pepe e mafai ona fesoasoani i le TREAT eczema, ae feteʻenaʻi iʻuga o loʻo i ai. O isi suʻesuʻega faʻaalia ai o le tuʻuina atu o le bifidobacteria ma le lactobacillus i fafine maʻitaga i le 2 masina talu ai o le maʻitaga, ona ave ai lea i le pepe mo le muamua 2 masina talu ona fanau mai, e mafai ona fesoasoani i le puipuia o le eczema. Ae feteenaʻi iʻuga o loʻo i ai. O le tuʻuina atu o le bifidobacteria ma le lactobacillus e naʻo pepe e ono aʻafia i le ono masina muamua o le olaga e le mafai ona taofia ai le faʻamaʻi.
• Faamaʻi Celiac. O suʻesuʻega muamua o loʻo faʻaalia ai o le avea o le bifidobacteria o se vaega o le taumafataga e leai se gluten e le faʻaleleia atili ai le manava ma faʻamaʻi o loʻo manaʻomia pe a faʻatusatusa i le taumafataga naʻo tamaiti o loʻo maua ile faʻamaʻi celiac.
• Faʻaleaʻoga i le manatuaina ma mafaufauga mafaufau i tagata matutua e sili atu nai lo le mea masani mo latou tausaga. O nisi suʻesuʻega faʻaalia ai o le avea o le bifidobacteria e faʻaleleia atili ai le manatuaina o tagata ma le paʻu o le mafaufau mafaufauga, ae foliga mai e le fesoasoani i le gagana poʻo le agavaʻa e uaʻi atu ai.
• Maʻa tui. O suʻesuʻega muamua e faʻaalia ai o le 'ai o fualaʻau yogurt ma bifidobacteria mo le 2 vaiaso e le faʻaititia ai nifo i tamaiti.
• Manava tata. Na maua ile suʻesuʻe muamua ole faʻaopopoina ole bifidobacteria ile Saccharomyces boulardii e fesoʻotaʻi ma atili faʻaititia le manava o tamaiti i le vave oso o le manava tata.
• Allergy i poleni cedar Iapani. O nisi suʻesuʻega faʻaalia ai o le aveina o le bifidobacteria i le taimi o le pollen vaitau e faʻaititia ai isu ma mata faʻailoga o le Iapani aliali poleni allergy. Ae e feteʻenaʻi iʻuga o loʻo iai. Bifidobacteria e foliga mai e le faʻaititia sneezing poʻo faʻaʻi faʻailoga e fesoʻotaʻi ma Iapani alava pollen allergy.
• O se faʻamaʻi oona i totonu o pepe pepe vave (nekrotizing enterocolitis poʻo le NEC). Suʻesuʻega faʻaalia ai o le tuʻuina atu o bifidobacteria naʻo pepe laiti e le mafai ona taofia ai lenei tulaga. Ae o le tuʻuina o le bifidobacteria ma le lactobacillus atonu e i ai sina aoga.
• Maʻi tuga e mafua mai i le susulu o le radiation. I le amataga o suʻesuʻega faʻaalia ai o vailaʻau-puipuia bifidobacteria mafai ona fesoasoani faʻaleleia atili puʻupuʻu ola i le togafitiga o radiation radiation. I le tuʻufaʻatasia ma vailaʻau faʻafomaʻi, o le bifidobacteria e aliali mai e fesoasoani e puipuia faʻamaʻi matautia mai le tutupu ma mafua ai se faʻamaʻi tuga.
• Rheumatoid gugu (RA).
• Faamaʻi pipisi o le fatugaʻo, tagāmimi, poʻo le urethra (urinary tract infection poʻo UTIs).
• Matua.
• Fatafata tiga, ono mafua mai i siama (mastitis).
• Kanesa.
• Faʻafitauli o le Bipolar.
• Faamaʻi pipisi i tagata e togafitia i vailaʻau kanesa.
• Atinaʻe o tamaiti.
• Tupuolaola ma atinaʻe i pepe vave.
• Faʻaitiitia pe poloka tafe o le bile mai le ate (cholestasis).
• Maʻi suka.
• Lactose le faapalepale.
• Faʻafitauli ole ate.
• Faamaʻi Lyme.
• Mumps.
• O tiga o maso e mafua mai i le faamalositino.
• Maualuga maualuga o kolisi poʻo isi gaʻo (lipids) i le toto (hyperlipidemia).
• Fula (mumu) ma fausiaina gaʻo i le ate i tagata e inu laʻititi pe leai foi ava malosi (nonalcoholic steatohepatitis po NASH).
• Fula (mumu) ma papala i totonu o le gutu (oral mucositis).
• O le manava tata e mafua mai i togafitiga o le radiation.
• Sui sui o siama aoga na aveʻese e le manava tata.
• Faʻafitauli o le manava.
• Totogi.
• Isi tulaga.

E tele molimau e manaʻomia e fua ai le bifidobacteria mo nei faʻaaogaina.

Tele o siama ma isi meaola e ola i o tatou tino masani. O le "Friendly" bacteria e pei o le bifidobacteria e mafai ona fesoasoani ia i tatou e talepe meaʻai, mitiia mea aoga, ma teteʻe ese i mea e le "faʻauo" e mafua ai faʻamaʻi pei o le manava tata.

A ave e le gutu: Bifidobacteria e MAFAI ONA SAFIA mo soifua maloloina tagata matutua pe a fai e le gutu talafeagai. I nisi tagata, o togafitiga ma le bifidobacteria e ono le fiafia ai le manava ma le manava, mafua ai le manava manava, manava ma kesi.

Lapataiga faʻapitoa & lapataʻiga:

Maitaga ma susu-fafagaina: O se faʻapitoa faʻapitoa o le bifidobacteria, Bifidobacterium bifidum, o MAFAI ONA SAFIA pe a fai e le gutu talafeagai mo le 6 vaiaso ao maʻito. E le lava faʻamatalaga faʻatuatuaina e uiga i le saogalemu o le aveina o isi ituaiga bifidobacteria ituaiga pe a fai o oe o maʻito pe faʻasusu. Tumau i le itu saogalemu ma aloese mai le faʻaaogaina.

Tamaiti: Bifidobacteria e MAFAI ONA SAFIA mo tamaiti le fiafia pe a fai e le gutu talafeagai. E ui lava na i ai ni tulaga o le faʻamaʻi toto i le bifidobacteria i pepe o loʻo tigaina lava, o nei mataupu e seasea maua.

Faʻavaivaia faiga puipuia: E i ai le popolega o "probiotics" ono tupu ola lelei i tagata ma le vaivai puipuia ma mafua ai faʻamaʻi. E ui lava e leʻi tupu faʻapitoa lenei mea ma le bifidobacteria, ae e seasea lava ni faʻalavelave e aʻafia ai isi ituaiga probiotic e pei o Lactobacillus. Afai e i ai sau vaivaiga vaivai faʻafitauli (faʻataʻitaʻiga, ua maua oe i le HIV / AIDS pe o loʻo feagai ma togafitiga o le kanesa), siaki ma lau fomaʻi soifua maloloina ae e leʻi faʻaaogaina le bifidobacteria.

Poloka i le manava: Lua mataupu o faʻamaʻi toto na lipotia mai mo pepe na tuuina bifidobacteria probiotics. I tulaga uma ia e lua, sa faia taotoga o le manava o pepe. E i ai le manatu o faʻamaʻi toto na mafua mai i le poloka o le manava na mafua mai i le manava o taotoga, lea na mafai ai e le bifidobacteria ona sopoia i totonu o le alatoto. I se tasi tulaga, o le aveina o bifidobacteria ina ua maeʻa le poloka o le manava na faʻasaʻoina e leʻi mafua ai se isi faʻamaʻi toto. O le mea lea o le aʻafiaga o faʻamaʻi toto e le o se popolega mo le tele o tamaiti pepe ave bifidobacteria. Ae o le bifidobacteria e tatau ona faʻaaoga ma le faʻaeteete pe aloese i ai i pepe meʻi manava poʻo poloka poloka.

Feololo

Faʻaeteete i lenei tuʻufaʻatasiga.

Vailaau vailaʻau

O vailaʻau faʻasaʻi e faʻaaogaina e faʻaititia ai siama leaga i le tino. E mafai foʻi ona faʻaititia vailaʻau faʻamama i le tino. Bifidobacteria o se ituaiga o siama faʻauo. O le aveina o vailaʻau faʻafomai faʻapea ma le bifidobacteria e ono faʻaititia ai le aoga o le bifidobacteria. Ina ia aloese mai lenei fesoʻotaʻiga, ave bifidobacteria oloa a itiiti mai e lua itula muamua pe pe a maeʻa vailaʻau.

E leai ni fesoʻotaʻiga lauiloa ma laʻau ma mea faʻaopopo.

E leai ni fesoʻotaʻiga iloa ma meaʻai.

O vailaʻau nei sa suʻesuʻeina i suʻesuʻega faasaienisi.

MATUTUA

E SAUNIU:

• Mo papala: 100 miliona i le 20 piliona kolone-fausia iunite o bifidobacteria na faʻaaogaina i aso uma. I le tele o tulaga, bifidobacteria e faia i aso uma mo 1-4 vaiaso. I nisi mataupu 5-60 piliona kolone-fausia iunite o bifidobacteria ma lactobacillus ua aveina i aso uma mo 1 vaiaso i le 1 masina.
• Mo se faʻaletonu taimi o le lapoʻa tele e mafua ai le manava tiga (itaitagofie bowel syndrome poʻo le IBS): Mo le faʻaleleia atili o manava ma manava o faʻailoga, 100 miliona i le 1 piliona o vaega o vaega o le bifidobacteria na faʻaaogaina i aso uma mo 4-8 vaiaso. Faʻapea foi, 5 piliona kolone-fausia iunite o bifidobacteria ma le lactobacillus ma le streptococcus ua faʻaaoga faʻalua i aso uma mo 4 vaiaso. Mo le faʻaleleia atili o le faʻanoanoaga ma le popole i tagata e iai le IBS, e 10 piliona iunite o loʻo avea ma vaega o le bifidobacteria na faʻaaoga faʻatasi i aso uma mo 6 vaiaso.
• Mo faʻamaʻi o ala vaalele: 3 piliona piliona-fausiaina iunite o bifidobacteria na faʻaaogaina i aso uma mo 6 vaiaso.
• Mo se faʻalavelave ina ua maeʻa taotoga mo ulcerative colitis (pouchitis): o se fualaʻau e oʻo atu i le 3 piliona kolone-fausia iunite o bifodobacteria ma le lactobacillus ma le streptococcus na tuʻuina atu faʻatasi i aso uma mo le oʻo atu i le 12 masina.
• Mo se faʻamaʻi pipisi auala e mafai ona taitai atu ai i papala (Helicobacter pylori poʻo H. pylori): 5 piliona piliona-fausiaina iunite o bifidobacteria ma le lactobacillus i aso uma mo le 1 vaiaso i le taimi o H. pylori togafitiga faʻatasi ai ma le tasi le vaiaso mulimuli ane na faʻaaogaina.
• Mo se ituaiga o faʻamaʻi manava manava (ulcerative colitis): Mo le faʻateleina o le faʻamagaloina, 3 kalama tutusa ma 900 piliona kolone-fausia iunite o lactobacillus faʻatasi ai ma le bifidobacteria ma le streptococcus na faʻaaogaina faʻatasi pe faʻalua i aso uma.

FANAU

E SAUNIU:

• Mo papala: 1-100 piliona piliona-fausia iunite o bifidobacteria i aso uma mo 4 vaiaso na faʻaaogaina i tamaiti matutua 3-16 tausaga.
• O se faʻaletonu taimi o le lapoʻa tele e mafua ai le manava tiga (itaitagofie bowel poʻo IBS): 10 piliona piliona-fausia vaega o bifidobacteria i aso uma mo 4 vaiaso na faʻaaogaina.
• Mo faʻamaʻi o ala vaalele: 2-10 piliona kolone-fausia iunite o tuʻufaʻatasia o bifidobacteria ma le lactobacillus ua faʻaaoga faʻalua i aso uma i tamaiti matutua 3-13 tausaga.
• Mo manava tata mafua mai rotavirus: Bifidobacteria, faʻatasi pe faʻatasi ma le streptococcus, sa faʻaaogaina i tamaiti e oʻo atu i le 3 tausaga le matutua. Faʻapea foi, bifidobacteria plus lactobacillus ua faʻaaoga faalua i aso uma mo 3 aso.
• Mo se ituaiga o faʻamaʻi manava manava (ulcerative colitis): E oʻo atu i le 1.8 piliona kolone-fausia iunite o bifidobacteria plus lactobacillus plus streptococcus na faʻaaogaina i aso uma e oʻo atu i le 1 tausaga i tamaiti 1-16 tausaga le matutua.

B. Bifidum, B. Breve, B. Infantis, B. lactis, B. Longum, Bifido, Bifido Bacterium Longum, Bifidobacterias, Bifidobactérie, Bifidobactéries, Bifidobacterium, Bifidobacterium adolescentis; Bifidobacterium animalis, Bifidobacterium bifidum; Bifidobacterium breve; Bifidobacterium infantis; Bifidobacterium lactis; Bifidobacterium longum, Bifidum, Bifidus, Bifidus Brevis, Bifidus Infantis, Bifidus Longum, Bifidobacteria Bifidus, Lactobacillus Bifidus, L. Bifidus, Probiotic, Probiotique.

Ina ia aoao atili e uiga i le auala na tusia ai lenei tusitusiga, faʻamolemole vaʻai i le Natura Faʻafomaʻi Maea Faʻamatalaga metotia

1. Athalye-Jape G, Minaee N, Nathan E, et al. Taunuʻuga i le laiti laiti ma le talafeagai mo pepe faʻailogaina pe a maeʻa Bifidobacterium breve M-16 V faʻaopoopoga. J Matern Fetal Neonatal Med. 2020; 33: 2209-2215. Vaʻai faʻamatala.
2. Wu G, Chen X, Cui N, et al. Aafiaga puipuia o Bifidobacterium supplementation i neonatal cholestasis i preterm neonates ma matua maualalo mamafa mamafa. Gastroenterol Res Faʻataʻitaʻiga. 2020; 2020: 4625315. Vaʻai faʻamatala.
3. Xiao J, Katsumata N, Bernier F, et al. Probiotic bifidobacterium breve i le faʻaleleia atili o le mafaufau galuega a tagata matutua ma masalomia le agavaʻa faʻaletonu mafaufau: O se randomized, lua-tauaso, placebo-pulea faʻataʻitaʻiga. J Alzheimers Dis. 2020; 77: 139-147. Vaʻai faʻamatala.
4. Lin CL, Hsu YJ, Ho HH, et al. Bifidobacterium longum subsp. longum OLP-01 faʻaopoopoga i le taimi o le onosaʻi tamoʻe aʻoaʻoga faʻaleleia atili faʻamalositino faʻatinoina i le ogatotonu ma le mamao-tamoʻe tamoʻe: O le faʻalua-tauaso faʻatautaia faʻataʻitaʻiga. Meaʻai. 2020; 12: 1972. Vaʻai faʻamatala.
5. Lewis ED, Antony JM, Crowley DC, et al. Malosiaga o Lactobacillus paracasei HA-196 ma Bifidobacterium longum R0175 i le faʻaitiitia o faʻailoga o le itaitagofie bowel syndrome (IBS): O se faʻasolosolo, placebo-pulea suesuega. Meaʻai. 2020; 12: 1159. Vaʻai faʻamatala.
6. Michael DR, Jack AA, Masetti G, et al. O se faʻatonutonuina faʻatonutonuina suʻesuʻega faʻaali faʻaopoopoga o le lapoʻa ma lapopoʻa tagata matutua ma lactobacilli ma bifidobacteria faʻaititia mamafa tino ma faʻaleleia le soifua maloloina. Sui Rep. 2020; 10: 4183. Vaʻai faʻamatala.
7. Czajeczny D, Kabzi & nacute; ska K, Wójciak RW. E fesoasoani le faʻaopopoga probiotic i le paʻu o le pauna? O se faʻataʻitaʻiga, tasi le tauaso, suʻesuʻeina placebo ma Bifidobacterium lactis BS01 ma Lactobacillus acidophilus LA02 faʻaopoopoga. Taumafa Pauna Faʻamama. 2020. Vaʻai faʻamatala.
8. Jiao X, Fu MD, Wang YY, Xue J, Zhang Y. Bifidobacterium ma Lactobacillus mo le puipuia o necrotizing enterocolitis i matua maualalo-fanau-mamafa mamafa pepe: o se faʻavasega iloiloga ma meta-auiliiliga. Lalolagi J Pediatr. 2020; 16: 135-142. Vaʻai faʻamatala.
9. Sadeghi-Bojd S, Naghshizadian R, Mazaheri M, Ghane Sharbaf F, Assadi F. Le aoga o le probiotic prophylaxis i le maeʻa ai o le muamua febrile urinary tract infection i tamaiti e masani ona maua i le urinary tract. J Pediatric Infect Dis Dis. 2020; 9: 305-310. Vaʻai faʻamatala.
10. Butler CC, Lau M, Gillespie D, et al. Aʻafiaga o le faʻaaoga probiotic i luga o vailaʻau faʻafomaʻi i tagata tausi fale: O se faʻataʻitaʻiga faʻafomaʻi falemaʻi. IAMA. 2020; 324: 47-56. Vaʻai faʻamatala.
11. Zhu XL, Tang XG, Qu F, Zheng Y, Zhang WH, Diao YQ. Bifidobacterium ono aoga le puipuia o le necrotizing enterocolitis i pepe laiti: O se faʻavasega iloiloga ma meta-auiliiliga. Int J Taotoga. 2019; 61: 17-25. Vaʻai faʻamatala.
12. Wang G, Feng D. Therapeutic effect o Saccharomyces boulardii tuʻufaʻatasia ma Bifidobacterium ma luga o le puipuia o sela i tamaiti o loʻo maua i le manava tata. Exp Ther Med. 2019; 18: 2653-2659. Vaʻai faʻamatala.
13. Sharif A, Kashani HH, Nasri E, Soleimani Z, Sharif MR. Le Matafaioi a Probiotics ile Togafitiga ole Dysentery: ose Faʻataʻitaʻiga ole Toʻalua-Tauaso Faʻafomaʻi. Probiotics Antimicrob Proteins. 2017; 9: 380-385. Vaʻai faʻamatala.
14. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. O saogalemu probiotics? Bifidobacterium bacteremia i se tamaititi ma le fatu fatu matuitui. Infez Med. 2019; 27: 175-178. Vaʻai faʻamatala.
15. Manzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W. Togafitiga le aoga o se sauniuniga probiotic mo non-ava malosi steatohepatitis: O se pailate faamasinoga. J Dig Dis. 2017; 18: 698-703. Vaʻai faʻamatala.
16. Kobayashi Y, Kuhara T, Oki M, Xiao JZ. Aʻafiaga o Bifidobacterium breve A1 i luga o le mafaufau gaioiga a tagata matutua ma manatua manatua faitioga: a randomized, lua-tauaso, placebo-pulea faʻataʻitaʻiga. Faʻamanuiaga Microbes. 2019; 10: 511-520. Vaʻai faʻamatala.
17. Jiang C, Wang H, Xia C, et al. O se faʻataʻitaʻiga, faʻalua-tauaso, faʻatautaia-faʻataʻitaʻia le faʻataʻitaʻiina o probiotics e faʻaititia ai le ogaoga o le oral mucositis faʻamalosia e chemoradiotherapy mo tagata mamaʻi ma nasopharyngeal carcinoma. Kanesa 2019; 125: 1081-1090. Vaʻai faʻamatala.
18. Inoue T, Kobayashi Y, Mori N, et al. Aʻafiaga o le tuʻufaʻatasi bifidobacteria faʻaopoopoga ma teteʻe toleniga i luga o le mafaufau gaioiga, tino tuʻufaʻatasiga ma manava manava o soifua maloloina matutua mataupu. Faʻamanuiaga Microbes. 2018; 9: 843-853. Vaʻai faʻamatala.
19. Dimidi E, Zdanaviciene A, Christodoulides S, et al. Faʻataʻitaʻi faʻataʻitaʻi falemaʻi: Bifidobacterium lactis NCC2818 probiotic vs placebo, ma aʻafiaga i le taimi o le feaveaʻiga o le manava, faʻailoga, ma le manava o meaola niniʻi i le tumau o le manava. Aliment Pharmacol Ther. 2019; 49: 251-264. Vaʻai faʻamatala.
20. Caglar E. Aʻafiaga o Bifidobacterium bifidum o loʻo iai yoghurt i siama tisiki nifo i tamaiti. J Clin Pediatr Dent. 2014; 38: 329-32. Vaʻai faʻamatala.
21. Zhang J, Ma S, Wu S, Guo C, Long S, Tan H. Aafiaga o Probiotic Faʻaopoopoga i Fafine Fafine ma Gestational Diabetes Mellitus: O se Faʻalapotopotoga Iloiloga ma Meta-Suʻesuʻega o Faʻataʻitaʻiina Faʻataʻitaʻia Faʻataʻitaʻiga. J Diabetes Res. 2019; 2019: 5364730. Vaʻai faʻamatala.
22. Slykerman RF, Kang J, Van Zyl N, et al. Aʻafiaga o le popo probiotic faʻaopoopoga i tamaiti malamalama, amio ma uiga a randomized, placebo-pulea faʻataʻitaʻiga. Acta Paediatr. 2018; 107: 2172-2178. Vaʻai faʻamatala.
23. Schmidt RM, Pilmann Laursen R, Bruun S, et al. Probiotics i le tuai o pepe faʻaititia le aʻafia o eczema: O se randomized pulea faʻamasinoga. Pediatr Allergy Immunol. 2019; 30: 335-340. Vaʻai faʻamatala.
24. Linn YH, Thu KK, Manumalo NHH. Aʻafiaga o Probiotics mo le Puipuia o Matuitui Matuʻu-Faʻaoso Diarrhea I Totonu kanesa Kanesa Patients: a Randomized Double-Blind Placebo-Controlled Study. Probiotics Antimicrob Proteins. 2019; 11: 638-647. Vaʻai faʻamatala.
25. Callaway LK, McIntyre HD, Barrett HL, et al. Probiotics mo le Puipuia o Gestational Diabetes Mellitus i le mamafa o fafine ma obesiti fafine: Sailiiliga mai le SPRING Faʻalua-Tauaso Faʻataʻitaʻi Faʻataʻitaʻiina Faʻataʻitaʻiga. Maʻi suka. 2019; 42: 364-371. Vaʻai faʻamatala.
26. Staudacher HM, Lomer MCE, Farquharson FM, et al. O se taumafataga maualalo i FODMAPs faʻaititia ai faʻailoga i tagata mamaʻi ma Irritable bowel Syndrome ma se Probiotic toe faʻafoʻi Bifidobacterium ituaiga: O se faʻataʻitaʻiina faʻataʻitaʻiina faʻataʻitaʻiina. Gastroenterology. 2017; 153: 936-947. Vaʻai faʻamatala.
27. Matsuoka K, Uemura Y, Kanai T, et al. Le aoga o le Bifidobacterium breve Milk fefete i le Tausia le Faʻamagaloina o Ulcerative Colitis. Dig Dis Sci. 2018; 63: 1910-1919. Vaʻai faʻamatala.
28. Liu J, Huang XE. Malosiaga o Bifidobacterium tetragenous mafai ola siama fualaʻau mo kanesa gasegase ma gaioiga manava. Asia Pac J Kanesa Muamua. 2014; 15: 10241-4. Vaʻai faʻamatala.
29. Lau AS, Yanagisawa N, Hor YY, et al. O le Bifidobacterium longum BB536 na faʻaitiitia ai faʻamaʻi o le manava o loʻo i luga ma faʻataʻitaʻiina talaaga o le microbiota gutu i tamaiti aʻoga muamua a Malaysia. Faʻamanuiaga Microbes. 2018; 9: 61-70. Vaʻai faʻamatala.
30. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Aʻafiaga o le 28-aso Bifidobacterium animalis subsp. lactis HN019 faʻaopoopoga i luga ole colonic transit time ma gastrointestinal faʻailoga i tagata matutua ma le manava manava: O le faʻalua-tauaso, faʻasolosolo, placebo-pulea, ma fualaʻau-amata faʻataʻitaʻiga. Faʻaaoga Microbes. 2018; 9: 236-251. Vaʻai faʻamatala.
31. Guardamagna O, Amaretti A, Puddu PE, et al. Bifidobacteria supplementation: aʻafiaga luga o le plasma lipid profiles i tamaiti ua le fiafia. Meaai paleni 2014; 30 (7-8): 831-6. Vaʻai faʻamatala.
32. Badehnoosh B, Karamali M, Zarrati M, et al. O aʻafiaga ole supiotic supplementation ile biomarkers ole pupuga, faʻamamaina ole oxidative ma maʻitaga e aliali mai ile maʻi suka. J Matern Fetal Neonatal Med. 2018 Me; 31: 1128-1136. Vaʻai faʻamatala.
33. Dickerson F, Adamos M, Katsafanas E, et al. Faʻaopopo probiotic microorganisms e puipuia rehospitalization i tagata mamaʻi ma matuitui mania: O se randomized pulea faʻamasinoga. Le mautonu Bipolar. 2018 Aper 25. Vaʻaia faʻavaʻa.
34. Pinto GS, Cenci MS, Azevedo MS, Epifanio M, Jones MH. Aʻafiaga o yogurt o loʻo iai Bifidobacterium animalis subsp. lactis DN-173010 probiotic i luga o nifo tui ma faua i orthodontic tagata mamaʻi. Caries Res. 2014; 48: 63-8. Vaʻai faʻamatala.
35. Zamani B, Golkar HR, Farshbaf S, et al. Tali faʻafomaʻi ma metabolic i probiotic faʻaopoopoga i tagata mamaʻi ma rheumatoid galu: a randomized, lua-tauaso, placebo-pulea faʻataʻitaʻiga. Int J Rheum Dis 2016; 19: 869-79. Vaʻai faʻamatala.
36. Pinto-Sanchez MI, Hall GB, Ghajar K, et al. O le Probiotic Bifidobacterium longum NCC3001 e faʻaititia ai le faʻanoanoaga ma suia ai gaioiga a le faiʻai: o se pailate suʻesuʻe i tagata mamaʻi e maua i le bowel syndrome. Gastroenterology 2017; 153: 448-459.e8. Vaʻai faʻamatala.
37. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Aʻafiaga o le faʻaopopoga probiotic i luga o le glycemic control ma lipid profiles i gestational maʻisuka: o se randomized, lua-tauaso, placebo-pulea faʻataʻitaʻiga. Maʻi suka Metab 2016; 42: 234-41. Vaʻai faʻamatala.
38. Jäger R, Purpura M, Stone JD, et al. Probiotic Streptococcus thermophilus FP4 ma Bifidobacterium breve BR03 faʻaopoopoga faʻamalieina faʻatinoina ma le tele-o-lafo faʻaiʻuga pe a maeʻa maso faʻaleagaina faʻamalositino. Meaʻai 2016; 8. pii: E642. Vaʻai faʻamatala.
39. Whorwell PJ, Altringer L, Morel J, et al. Malosiaga o se encapsulated probiotic Bifidobacterium infantis 35624 i fafine ma itagofie bowel syndrome. Am J Gastroenterol. 2006 Iulai; 101: 1581-90. Vaʻai faʻamatala.
40. Lau CS, Chamberlain RS. Probiotics e aoga i le puipuia Clostridium difficile-fesoʻotaʻi manava: o se faʻavasega iloiloga ma meta-auiliiliga. Int J Gen Med. 2016; 9: 27-37. Vaʻai faʻamatala.
41. Stenman LK, Lehtinen MJ, Meland N, et al. Probiotic Faʻatasi ma pe leai Fiber Pulea Tino gaʻoa tele, Faʻatasi ma Serum Zonulin, i le mamafa ma Obese tagata matutua-Randomized Faʻataʻitaʻia Faʻataʻitaʻiga. EBioMedicine 2016; 13: 190-200. Vaʻai faʻamatala.
42. Sato S, Uchida T, Kuwana S, et al. Bacteremia faʻamalosia e Bifidobacterium breve i se pepe fou ma cloacal exstrophy. Pediatr Int. 2016; 58: 1226-8. Vaʻai faʻamatala.
43. Jayasimhan S, Yap NY, Roest Y, Rajandram R, Chin KF. Malosiaga o sauniuniga sela microbial i le faʻaleleia atili o le manava faʻavaitaimi: o se faʻasolosolo, faʻalua-tauaso, faʻataʻitaʻiga taofiofia placebo. Clin Nutr 2013; 32: 928-34. Vaʻai faʻamatala.
44. Han K, Wang J, Seo JG, Kim H. Faʻatinoina o faʻalua-peleue probiotics mo itaitagofie bowel syndrome: o se randomized faʻalua-tauaso faʻataʻitaʻia le faʻamasinoga. J Gastroenterol. 2017; 52: 432-443. Vaʻai faʻamatala.
45. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Ole tele o ituaiga probiotics foliga mai o le sili atu aoga probiotics i le puipuia o le necrotizing enterocolitis ma le olaga nei: O se toe faʻaleleia meta-auiliiliga. PLoS Tasi. 2017; 12: e0171579. Vaʻai faʻamatala.
46. Bastürk A, Artan R, Yilmaz A. Malosiaga o synbiotic, probiotic, ma prebiotic togafitiga mo itaitagofie bowel syndrome i tamaiti: O se randomized pulea faamasinoga. Turk J Gastroenterol 2016; 27: 439-43. Vaʻai faʻamatala.
47. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics mo le Puipuia o le Manava o le Antibiotic-Associated i Outpatients-O le Iloiloina ma le Meta-Suʻesuʻega. Antibiotics (Basel). 2017; 6. Vaʻai faʻamatala.
48. Al Faleh K, Anabrees J. Probiotics mo le puipuia o le necrotizing enterocolitis i pepe laiti. Cochrane Database Syst Rev. 2014;: CD005496. Vaʻai faʻamatala.
49. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. O le aafiaga o probiotics i luga o le manava o le tino i tagata matutua: o se iloiloga faʻavasega ma meta-auiliiliina o faʻatonutonuina faʻataʻitaʻiga tofotofoga. Am J Clin Nutr. 2014; 100: 1075-84. Vaʻai faʻamatala.
50. Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. O se faʻataʻitaʻiga faʻataʻitaʻi placebo-pulea faʻalua i le Lactobacillus acidophilus La-5 ma le Bifidobacterium animalis subsp. lactis BB-12 mo le tausiga o le faʻamagaloina i ulcerative colitis. J Crohns Colitis 2011; 5: 115-21. Vaʻai faʻamatala.
51. Shen J, Zuo ZX, Mao AP. Aʻafiaga o probiotics i le faʻamalosia o le faʻamagaloina ma le tausia o togafitiga i ulcerative colitis, faʻamaʻi o Crohn, ma pouchitis: meta-auiliiliina o faʻatonutonuina faʻatonutonuina faʻataʻitaʻiga. Inflamm bowel Dis. 2014; 20: 21-35. Vaʻai faʻamatala.
52. Park MS, Kwon B, Ku S, Ji GE4. Le aoga ole Bifidobacterium longum BORI ma Lactobacillus acidophilus AD031 Probiotic Togafitiga i Tamaiti ma siama Rotavirus. Meaʻai. 2017; 9. pii: E887. Vaʻai faʻamatala.
53. Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Aafiaga o le probiotic fefete susu luga o faʻailoga ma fualaʻau toto i tagata mamaʻi ma gasegase bowel syndrome: o se randomized, placebo-pulea faʻataʻitaʻiga. Scand J Gastroenterol 2011; 46: 663-72. Vaʻai faʻamatala.
54. Simrén M, Ohman L, Olsson J, et al. Togafitiga faʻafomaʻi: o aʻafiaga o le susu faʻapipiina o loʻo i ai ni siama probiotic e tolu i tagata mamaʻi e maua i le manava o le manava - o se suesuega faʻasolosolo, faʻalua-tauaso, faʻatonutonu Aliment Pharmacol Ther 2010; 31: 218-27. Vaʻai faʻamatala.
55. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics mo le puipuia ole tamaititi vailaʻau faʻafomaʻi o le manava tata. Cochrane Database Syst Rev. 2015;: CD004827. Vaʻai faʻamatala.
56. O'Callaghan A, van Sinderen D. Bifidobacteria ma a latou matafaioi o tagata o le Human Gut Microbiota. Luma Microbiol. 2016 Jun 15; 7: 925. Vaʻai faʻamatala.
57. Olivares M, Castillejo G, Varea V, Sanz Y.Faʻalua-tauaso, faʻasolosolo, placebo-pulea faʻataʻitaʻi faʻamasino faʻataʻitaʻiga e iloilo ai aʻafiaga o Bifidobacterium longum CECT 7347 i tamaiti e leʻi leva na faʻamaonia faʻamaʻi celiac. Br J Nutr. 2014 Iulai 14; 112: 30-40. Vaʻai faʻamatala.
58. Hojsak I, Tokic Pivac V, Mocic Pavic A, Pasini AM, Kolacek S. Bifidobacterium animalis subsp. lactis le mafai ona puipuia le masani ai siama i tamaiti falemai: o se randomized, lua-tauaso, placebo-pulea suesuega. Am J Clin Nutr. 2015 Mati; 101: 680-4. Vaʻai faʻamatala.
59. Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Aafiaga o le probiotic leaga Bifidobacterium animalis subsp. lactis, BB-12®, i luga o le faʻateleina o le faʻataʻamilomilo i mataupu soifua maloloina ma le maualalo o le paʻu ma le manava o le manava. Br J Nutr. 2015 Nov 28; 114: 1638-46. Vaʻai faʻamatala.
60. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR; Probiotics i Preterm Tamaiti Suesueina Vaega Galulue. Bifidobacterium breve BBG-001 i tamaititi laiti: o le faʻasolosolo pulea vaega 3 tofotofoga. Lancet 2016 Fepuari 13; 387: 649-60. Vaʻai faʻamatala.
61. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, Mack D. Lactobacilli ma le bifidobacteria i le puipuia o le manava o le manava faʻafesoʻotaʻi ma Clostridium difficile diarrhea i le matua. falemai (PLACIDE): o se faʻafitauli, lua-tauaso, placebo-pulea, multicentre faʻamasinoga. Lancet 2013 Oketopa 12; 382: 1249-57. Vaʻai faʻamatala.
62. Roberfroid MB. Prebiotics ma probiotics: o ni meaʻai meaʻai? Am J Clin Nutr. 2000; 71 (6 Faʻaopoopoga): 1682S-7S; talanoaga 1688S-90S. Vaʻai faʻamatala.
63. Wang YH, Huang Y. Aafiaga o Lactobacillus acidophilus ma Bifidobacterium bifidum supplementation i le tulaga masani tolu togafitiga i Helicobacter pylori eradication ma malosi suiga i fualaʻau fugalaʻau. Lalolagi J Microbiol Biotechnol. 2014; 30: 847-53. Vaʻai faʻamatala.
64. Wang ZH, Gao QY, Fang JY. Meta-suʻesuʻega o le aoga ma le saogalemu o Lactobacillus-aofia ai ma Bifidobacterium-o loʻo i ai probiotic compound sauniuniga i Helicobacter pylori eradication togafitiga. J Clin Gastroenterol. 2013; 47: 25-32. Vaʻai faʻamatala.
65. Videlock EJ, Cremonini F. Meta-auiliiliga: probiotics i vailaʻau-fesoʻotaʻi manava tata. Aliment Pharmacol Ther. 2012; 35: 1355-69. Vaʻai faʻamatala.
66. Tomasz B, Zoran S, Jaroslaw W, Ryszard M, Marcin G, Robert B, Piotr K, Lukasz K, Jacek P, Piotr G, Przemyslaw P, Michal D. Faʻaaoga umi o probiotics Lactobacillus ma Bifidobacterium ei ai sona aafiaga faʻapitoa i o le tutupu ma le ogaoga o pouchitis: a randomized prospective suesuega. Biomed Res Int. 2014; 2014: 208064. Vaʻai faʻamatala.
67. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M, Minakari M, Shavakhi S, Gholamrezaei A. O le aafiaga o le multistrain probiotic compound i luga o le bismuth-o loʻo i ai le quadruple togafitiga mo Helicobacter pylori siama: o se tulaga faʻasolosolo placebo -le suʻesuʻe tauaso. Helicobacter. 2013; 18: 280-4. Vaʻai faʻamatala.
68. Rerksuppaphol S, Rerksuppaphol L. Faʻataʻitaʻia le faʻataʻitaʻia o faʻataʻitaʻiga e faʻaitiitia ai le malulu masani i tamaiti aʻoga. Pediatr Int. 2012; 54: 682-7. Vaʻai faʻamatala.
69. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation i le taimi o le maitaga ma susu-fafagaina faʻaititia le lamatiaga o le eczema i le pepe. J Allergy Clin Immunol. 2012; 130: 1355-60. Vaʻai faʻamatala.
70. Langkamp-Henken B, Rowe CC, Ford AL, Christman MC, N steal C Jr, Khouri L, Specht GJ, Girard SA, Spaiser SJ, Dahl WJ. O le Bifidobacterium bifidum R0071 e maua ai le tele o aso soifua maloloina ma le pasene paʻu o tamaiti aʻoga faʻamamafaina tamaiti aʻoga lipotia se aso o le malulu / fulū: o se randomized, lua-tauaso, placebo-pulea suesuega. Br J Nutr. 2015 14; 113: 426-34. Vaʻai faʻamatala.
71. Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, Peterson C, Morris J, Chaloner C, Murray CS, Woodcock A. Togafitiga ma faʻalua puipuiga aafiaga o le probiotics Lactobacillus paracasei poʻo Bifidobacterium lactis i vave pepe fanau : faʻasolosolo faʻatonutonuina faʻataʻitaʻiga ma le tulitatao seʻia oʻo ile 3 tausaga Clin Exp Allergy 2012; 42: 112-22. Vaʻai faʻamatala.
72. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R, Echániz-Aviles MO. Faʻalua-tauaso, faʻasolosolo falemaʻi faʻataʻitaʻi e iloilo le aoga o probiotics i pepe fou pepe e paʻu le mamafa nai lo le 1500 g i le puipuia o le necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013; 98: F5-9. Vaʻai faʻamatala.
73. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Togafitiga uumi ma probiotics i muamua tagata mamaʻi gasegase ma itaitagofie bowel syndrome - o se randomized, lua-tauaso, placebo pulea faʻataʻitaʻiga. Scand J Gastroenterol 2013; 48: 1127-35. Vaʻai faʻamatala.
74. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, Plummer SF, Wang D, Morgan G. Probiotics i le puipuia o eczema: o se faʻataʻitaʻiga faʻatonutonuina faʻataʻitaʻi. Arch Dis Child 2014; 99: 1014-9. Vaʻai faʻamatala.
75. Das RR.Singh M, Shafiq N. Probiotics i Togafitiga o Allergic Rhinitis. Tusi o Faʻalapotopotoga a le Lalolagi Atoa 2010; 3: 239-244.
76. Seki M, Igarashi T Fukuda Y Simamura S Kaswashima T Ogasa K. O le aafiaga o le Bifidobacterium galueaina susu i luga o le "masani" i totonu o se vaega matutua. Nutr Meaʻai 1978; 31: 379-387.
77. Kageyama T, Nakano Y Tomoda T. Suʻesuʻega Faʻatusatusa i Tautalaga Tautala o Nisi Bifidobacterium Sauniuniga. Vailaau ma Paiolo (Iapani) 1987; 115: 65-68.
78. Kageyama T, Tomoda T Nakano Y. Le Aʻafiaga o le Bifidobacterium Faʻataʻitaʻiga i Tagata mamaʻi ma Leukemia. Bifidobacteria Microflora. 1984; 3: 29-33.
79. Ballongue J, Grill J Baratte-Euloge P. Action sur la flore usus o le lauti fermentés au Bifidobacterium. Lait 1993; 73: 249-256.
80. Ogata T, Kingaku M Yaeshima T Teraguchi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Lino H. Aafiaga o Bifidobacterium longum BB536 yogurt pulega i luga o le siosiomaga siama o soifua maloloina tagata matutua. Microb Ecol Health Dis 1999; 11: 41-46.
81. Tomoda T, Nakano Y Kageyama T. Fesuiaʻiga i Laʻititi Vaega o Tumau Faʻapipiʻi Fomaʻi Flora i le taimi o Faʻatonutonuina o Anticancer poʻo Immunosuppressive Fualaʻau. Faʻafomaʻi ma Biology (Iapani) 1981; 103: 45-49.
82. Tomoda T, Nakano Y Kageyama T. Intestinal Candida Overgrowth ma Candida siama i Tagata Maʻi ma Leukemia: Aʻafiaga o Bifidobacterium Faʻafoeina. Bifidobacteria Microflora 1988; 7: 71-74.
83. Araya-Kojima Tomoko, Yaeshima Tomoko Ishibashi Norio Shimamura Seiichi Hayasawa Hirotoshi. Aʻafiaga faʻafitauli o le Bifidobacterium longum BB536 i luga o le afaina o faʻamaʻi pipisi. Bifidobacteria Microflora 1995; 14: 59-66.
84. Namba K, Yaeshima T Ishibashi N Hayasawa H ma Yamazaki Shoji. Aafiaga taofiofia o Bifidobacterium longum i Enterohemorrhagic Escherichia coli O157: H7. Bioscience Microflora 2003; 22: 85-91.
85. Igarashi M, Iiyama Y Kato R Tomita M Asami N Ezawa I. Aʻafiaga o Bifidobacterium longum ma lactulose i luga o le malosi o ponaivi i ovariectomized osteoporosis faʻataʻitaʻiga fua faatatau. Bifidus 1994; 7: 139-147.
86. Yaeshima T, Takahashi S Ota S Nakagawa K Ishibashi N Hiramatsu A Ohashi T Hayasawa H Iino H. Aafiaga o suamalie suamalie o loʻo iai le Bifidobacterium longum BB536 i luga o le faʻateleina o le paʻu ma uiga faʻanumera o soifua maloloina tagata matutua: O se faʻatusatusaga ma suamalie yogurt masani. Kenko Eiyo Shokuhin Kenkyu 1998; 1 (3/4): 29-34.
87. Yaeshima T, Takahashi S Matsumoto N Ishibashi N Hayasawa H Lino H. Aafiaga o le yogurt o loʻo i ai le Bifidobacterium longum BB536 i luga o le siʻosiʻomaga siʻosiʻomaga, uiga faʻanatura ma le faʻateleina tele o le faʻaleagaina: O se faʻatusatusaga ma masani yogurt. Biosci Microflora 1997; 16: 73-77.
88. Xiao J, Kondol S Odamaki T Miyaji K Yaeshima T Iwatsuki K Togashi H Benno Y. Aʻafiaga o le yogurt o loʻo iai le Bifidobacterium longum BB 536 i luga o le faʻataʻamilosaga masani ma fecal uiga o soifua maloloina tagata matutua: O le faʻalua-tauaso koluse i luga o suʻesuʻega. Iapani Tusitusiga o Lactic Acid Bacteria 2007; 18: 31-36.
89. Yaeshima T, Takahashi S Ogura A Konno T Iwatsuki K Ishibashi N Hayasawa H. Aafiaga o le susu e le faʻafefeteina o loʻo i ai Bifidobacterium longum BB536 i luga o le Defecation Frequency ma Fecal Characteristics i Soifua Maloloina Matutua. Tusi o Tala o Meaʻai Taumafa 2001; 4: 1-6.
90. Ogata T, Nakamura T Anjitsu K Yaeshima T Takahashi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Iino H. Aafiaga o le Bifidobacterium longum BB536 pulega i luga o le siʻosiʻomaga siʻitia, faʻataʻamilosaga taimi masani ma fecal uiga o tagata volenitia. Biosci Microflora 1997; 16: 53-58.
91. Iwabuchi N, Hiruta N Kanetada S Yaeshima T Iwatsuki K Yasui H. Aafiaga o Intranasal Faʻatonutonuina o Bifidobacterium longum BB536 luga Mucosal Immune System i Respiratory Tract ma Influenza Virus siama i Isumu. Susu Saienisi 2009; 38: 129-133.
92. Sekine I, Yoshiwara S Homma N Takanori H Tonosuka S. Aafiaga o le Bifidobacterium-o loʻo i ai le susu i luga o le chemiluminescence tali o le peripheral leukocytes ma o lona uiga o le tino o le sela mumu o sela toto - o le ono mafai ai o le Bifidobacterium i le faʻagaina o macrophages. Togafitiga (Iapani) 1985; 14: 691-695.
93. Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N., ma Reddy, BS Bifidobacterium longum, o se lactic acid-gaosia siama siama taofia ai le kanesa kanesa ma suia le ogatotonu biomarkers o le kolone kanesa o le tino . Carcinogenesis 1997; 18: 833-841. Vaʻai faʻamatala.
94. Reddy, B. S. ma Rivenson, A. Faʻalavelaveina aafiaga o Bifidobacterium longum i luga o kolone, mammary, ma le kanesa kanesa na mafua mai i le 2-amino-3-methylimidazo [4,5-f] quinoline, o se meaai mutagen. Kanesa Res. 9-1-1993; 53: 3914-3918. Vaʻai faʻamatala.
95. Yamazaki, S., Machii, K., Tsuyuki, S., Momose, H., Kawashima, T., ma Ueda, K. Immunological tali atu i monoassociated Bifidobacterium longum ma a latou sootaga i le puipuia o siama osofaia. Immunology 1985; 56: 43-50. Vaʻai faʻamatala.
96. Kondo, J., Xiao, J. Z., Shirahata, A., Baba, M., Abe, A., Ogawa, K., ma Shimoda, T. Faʻatonuina aafiaga o Bifidobacterium longum BB536 i luga o le faʻataʻamilomilo i tagata matutua tagata gasegase maua fafagaina ulufale. Lalolagi J Gastroenterol 4-14-2013; 19: 2162-2170. Vaʻai faʻamatala.
97. Akatsu, H., Iwabuchi, N., Xiao, JZ, Matsuyama, Z., Kurihara, R., Okuda, K., Yamamoto, T., ma Maruyama, M. Aafiaga Faʻafomaʻi o Probiotic Bifidobacterium longum BB536 i luga o le Immune Function ma Intestinal Microbiota i Tagata Matutua Matua Mauaina Enteral Tube Fafagaina. JPEN J Parenter Enteral Nutr 11-27-2012; Vaʻai faʻamatala.
98. Odamaki, T., Sugahara, H., Yonezawa, S., Yaeshima, T., Iwatsuki, K., Tanabe, S., Tominaga, T., Togashi, H., Benno, Y., ma Xiao, JZ Effect o le tautala tuʻuina o yogurt o loʻo i ai Bifidobacterium longum BB536 i luga o sela numera o enterotoxigenic Bacteroides fragilis i microbiota. Anaerobe. 2012; 18: 14-18. Vaʻai faʻamatala.
99. Iwabuchi, N., Xiao, J. Z., Yaeshima, T., ma Iwatsuki, K. Tautala tuʻuina o Bifidobacterium longum ameliorates faʻamaʻi pipisi siama influenza i isumu. Biol. Faʻafetai. 2011; 34: 1352-1355. Vaʻai faʻamatala.
100. Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, JC, Blum, S., Steenhout, P., Benyacoub , J., ma Schiffrin, EJ Tolerance, saogalemu, ma aafiaga i le faecal microbiota o se enteral formula faʻatasi ma muamua ma probiotics i tamaiti o loʻo gasegase tigaina. J Pediatr.Gastroenterol.Nutr. 2011; 53: 174-181. Vaʻai faʻamatala.
101. Hascoet, J. M., Hubert, C., Rochat, F., Legagneur, H., Gaga, S., Emady-Azar, S., ma Steenhout, P. G. Aafiaga o le fua faatatau i le atinaʻeina o le microbiota o le manava o le pepe. J Pediatr.Gastroenterol.Nutr. 2011; 52: 756-762. Vaʻai faʻamatala.
102. Firmansyah, A., Dwipoerwantoro, P. G., Kadim, M., Alatas, S., Conus, N., Lestarina, L., Bouisset, F., ma Steenhout, P. O le alualu i luma o le tuputupu aʻe o tamaiti laiti na fafagaina se susu na i ai synbiotics. Asia Pac.J Clin.Nutr. 2011; 20: 69-76. Vaʻai faʻamatala.
103. Tang, M. L., Lahtinen, S. J., ma Boyle, R. J. Probiotics ma faʻamalositino: aʻafiaga i falemaʻi. Curr.Opin.Pediatr. 2010; 22: 626-634. Vaʻai faʻamatala.
104. Namba, K., Hatano, M., Yaeshima, T., Takase, M., ma Suzuki, K. Aafiaga o le Bifidobacterium longum BB536 pulega i luga o siama influenza, fualaʻau vailaʻau tui puipuia fualaʻau, ma sela-faʻatulagaina puipuiga i tagata matutua. Biosci.Biotechnol.Biochem. 2010; 74: 939-945. Vaʻai faʻamatala.
105. Gianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., Gilardini, C., Zonenschain, D., Nespoli, A., ma Braga, M. O se faʻataʻitaʻiga faʻalua-tauaso faʻataʻitaʻiga luga perioperative faʻatautaiga o probiotics i colorectal kanesa gasegase. Lalolagi J Gastroenterol. 1-14-2010; 16: 167-175. Vaʻai faʻamatala.
106. Andrade, S. ma Borges, N. Aʻafiaga o le fefete susu o loʻo iai le Lactobacillus acidophilus ma le Bifidobacterium longum i luga o le lipid plasma o fafine e iai le koleni masani pe feololo foʻi. J.Dairy Res. 2009; 76: 469-474. Vaʻai faʻamatala.
107. Rouge, C., Piloquet, H., Butel, MJ, Berger, B., Rochat, F., Ferraris, L., Des, Robert C., Legrand, A., de la Cochetiere, MF, N'Guyen, JM, Vodovar, M., Voyer, M., Darmaun, D., ma Roze, JC Tautala tuʻufaʻatasi ma probiotics i matua maualalo-fanau-mamafa mamafa pepe: o se randomized, faalua-tauaso, placebo-pulea faʻamasinoga. Am.J Clin.Nutr. 2009; 89: 1828-1835. Vaʻai faʻamatala.
108. Iwabuchi, N., Takahashi, N., Xiao, JZ, Yonezawa, S., Yaeshima, T., Iwatsuki, K., ma Hachimura, S. O aafiaga ogaoga o le Bifidobacterium longum i le gaosiaina o Th2-faatosina kemokini na mafua mai i le T fesoʻotaʻiga sela-antigen-faʻaalia sela. FEMS Immunol.Med.Microbiol. 2009; 55: 324-334. Vaʻai faʻamatala.
109. Takeda, Y., Nakase, H., Namba, K., Inoue, S., Ueno, S., Uza, N., ma Chiba, T. Faʻatonutonuina o T-bet ma fusi soʻotaga molemole e Bifidobactrium longum faʻaleleia colonic fulū o le papala papala. Fula. Punouga. 2009; 15: 1617-1618. Vaʻai faʻamatala.
110. Soh, SE, Aw, M., Gerez, I., Chong, YS, Rauff, M., Ng, YP, Wong, HB, Pai, N., Lee, BW, ma Shek, LP Probiotic supplementation i le muamua 6 masina o le olaga i lamatiaga tamaiti Asia - aʻafiaga i eczema ma atopic sensitization i le tausaga o le 1 tausaga. Clin.Exp.Allergy 2009; 39: 571-578. Vaʻai faʻamatala.
111. Odamaki, T., Xiao, JZ, Sakamoto, M., Kondo, S., Yaeshima, T., Iwatsuki, K., Togashi, H., Enomoto, T., ma Benno, Y. Tufatufaina o ituaiga eseese o le Bacteroides fragilis kulupu i tagata taʻitasi ma Iapani arasi pollinosis. Appl. Siosiomaga. Microbiol. 2008; 74: 6814-6817. Vaʻai faʻamatala.
112. del Giudice, M. M. ma Brunese, F. P. Probiotics, prebiotics, ma allergy i tamaiti: o le a le mea fou i le tausaga talu ai? J Clin.Gastroenterol. 2008; 42 Faʻaopopo 3 Pt 2: S205-S208. Vaʻai faʻamatala.
113. Chouraqui, JP, Grathwohl, D., Labaune, JM, Hascoet, JM, de, Montgolfier, I, Leclaire, M., Giarre, M., ma Steenhout, P. Iloiloina o le saogalemu, faapalepale, ma puipuiga puipuiga faasaga i manava tata o pepe faʻatulagaina aofia ai palu faʻafefiloi o probiotics poʻo probiotics ma prebiotics i se faʻatonutonuina faʻatonutonuina faʻamasinoga. Am.J Clin.Nutr. 2008; 87: 1365-1373. Vaʻai faʻamatala.
114. Matsumoto, T., Ishikawa, H., Tateda, K., Yaeshima, T., Ishibashi, N., ma Yamaguchi, K. Tautinoga tuufofoga o le Bifidobacterium longum e taofia ai le maua e le Pseudomonas aeruginosa sepsis i isumu. J Appl.Microbiol. 2008; 104: 672-680. Vaʻai faʻamatala.
115. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, T., ma Benno, Y. Aʻafiaga o Bifidobacterium longum BB536 faʻaaogaina i faecal microbiota i tagata taʻitasi ma Iapani cedar pollinosis i le taimi o pollen vaitau. J Med.Microbiol. 2007; 56 (Pt 10): 1301-1308. Vaʻai faʻamatala.
116. Iwabuchi, N., Takahashi, N., Xiao, J. Z., Miyaji, K., ma Iwatsuki, K. In vitro Th1 cytokine-tutoatasi Th2 suppressive aafiaga o bifidobacteria. Microbiol.Immunol. 2007; 51: 649-660. Vaʻai faʻamatala.
117. Xiao, JZ, Kondo, S., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., ma Enomoto, T. Suiga i le maualuga o le plasma TARC i le taimi o le vaitau o pollen cedar a Iapani ma sootaga ma atinaʻe faʻailoga. Int.Arch.Allergy Immunol. 2007; 144: 123-127. Vaʻai faʻamatala.
118. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, T., ma Benno, Y. Fesuiaʻiga o fecal microbiota i tagata taʻitasi ma Iapani cedar pollinosis i le taimi o le pollen vaitau ma aafiaga o probiotic faʻaaogaina. J Suʻesuʻega.Allergol.Clin.Immunol. 2007; 17: 92-100. Vaʻai faʻamatala.
119. Xiao, JZ, Kondo, S., Yanagisawa, N., Miyaji, K., Enomoto, K., Sakoda, T., Iwatsuki, K., ma Enomoto, T. O le aoga o le probiotic Bifidobacterium longum mo le togafitia o faʻailoga. o Iapani alava pollen afaina i mataupu iloiloina i totonu o se siʻosiʻomaga gaioiga iunite. Allergol.Int. 2007; 56: 67-75. Vaʻai faʻamatala.
120. Puccio, G., Cajozzo, C., Meli, F., Rochat, F., Grathwohl, D., ma Steenhout, P. Iloiloga faʻafomaʻi o se fou amata metotia mo pepe o loʻo i ai ola Bifidobacterium longum BL999 ma prebiotics. Meaʻai paleni 2007; 23: 1-8. Vaʻai faʻamatala.
121. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, K., ma Enomoto, T. Probiotics i le togafitia o le Japanese cedar pollinosis: o le faʻalua-tauaso placebo-pulea faʻamasinoga. Clin.Exp.Allergy 2006; 36: 1425-1435. Vaʻai faʻamatala.
122. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, K., ma Enomoto, T. Aʻafiaga o le probiotic Bifidobacterium longum BB536 [faʻasaʻosaʻoina] i le faʻamamaina o faʻamaʻi o le falemaʻi ma le fesuiaʻiga o le maualuga o le cytokine plasma o le Japanese cedar pollinosis i le vaitaimi o le poleni O se faʻataʻitaʻiga faʻalua-tauaso, faʻataʻitaʻiga faʻatonutonuina placebo. J Suʻesuʻega.Allergol.Clin.Immunol. 2006; 16: 86-93. Vaʻai faʻamatala.
123. Bennet, R., Nord, C. E., ma Zetterstrom, R. Faʻaletonu nofoia o le manava o pepe faatoa fananau mai e ala i le tautala tuʻuina bifidobacteria ma lactobacilli. Acta Paediatr. 1992; 81: 784-787. Vaʻai faʻamatala.
124. Zsivkovits, M., Fekadu, K., Sontag, G., Nabinger, U., Huber, WW, Kundi, M., Chakraborty, A., Foissy, H., ma Knasmuller, S. Puipuiga o heterocyclic amine-faatosina. DNA faʻaleagaina i kolone ma ate o isumu e ala eseese lactobacillus. Carcinogenesis 2003; 24: 1913-1918. Vaʻai faʻamatala.
125. Orrhage, K., Sjostedt, S., ma Nord, C. E. Aʻafiaga o faʻaopoopoga ma lactic acid siama ma oligofructose i luga o le manava microflora i le taimi o pulega o cefpodoxime proxetil. J Antimicrob.Chemother. 2000; 46: 603-612. Vaʻai faʻamatala.
126. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility o bifidobacterial ituaiga tufatufaina i le maketi Iapani.Biosci Biotechnol Biochem. 2010; 74: 336-42. Vaʻai faʻamatala.
127. AlFaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics mo le puipuia o le necrotizing enterocolitis i pepe laiti. Cochrane Database of Systematic Review 2011, Lomiga 3. Art. Leai.: CD005496. DOI: 10.1002 / 14651858.CD005496.pub3. Vaʻai faʻamatala.
128. Tabbers MM, Milliano I, Roseboom MG, Benninga MA. E aoga le Bifidobacterium breve ile togafitiga ole manava ole tamaititi? Iʻuga mai se suʻesuʻega pailate. Nutr J 2011; 10:19. Vaʻai faʻamatala.
129. Leyer GJ, Li S, Mubasher ME, et al. Probiotic effects i le malulu ma le fulū-pei faʻailoga tupu ma le umi i tamaiti. Pediatrics 2009; 124: e172-e179. Vaʻai faʻamatala.
130. Miele E, Pascarella F, Giannetti E. et al. Aʻafiaga o le probiotic sauniuniga (VSL # 3) i luga o le faʻaulufaleina ma le tausiga o le faʻamagaloina o tamaiti ma ulcerative colitis. Am J Gastroenterol 2009; 104: 437-43. Vaʻai faʻamatala.
131. Kuhbacher T, Ott SJ, Helwig U, et al. Siama ma fula microbiota e fesoʻotaʻi ma le probiotic therapy (VSL # 3) i le pouchitis. Gut 2006; 55: 833-41. Vaʻai faʻamatala.
132. Bibiloni R, Fedorak RN, Tannock GW, et al. VSL # 3 probiotic-paluga faʻamalosia ai le faʻamagaloina o tagata mamaʻi ma toaga ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-46. Vaʻai faʻamatala.
133. Tursi A, Brandimarte G, Giorgetti GM, et al. Lalo-inumaga balsalazide ma se maualuga-malosi sauniuniga probiotic e sili atu le aoga nai lo le balsalazide na o ia po o le mesalazine i le togafitiga o matuitui agamalu-i-feololo ulcerative colitis. Med Sci Monit 2004; 10: PI126-31. Vaʻai faʻamatala.
134. Kato K, Mizuno S, Umesaki Y, et al. Faʻataʻitaʻina le placebo-pulea faʻataʻitaʻiga iloiloina le aʻafiaga o bifidobacteria-faʻasusu susu i gaioiga ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 1133-41. Vaʻai faʻamatala.
135. McFarland LV. Meta-auiliiliga o probiotics mo le puipuia o vailaʻau faʻafomaʻi fesoʻotaʻi ma le togafitiga o Clostridium difficile faʻamaʻi. Am J Gastroenterol 2006; 101: 812-22. Vaʻai faʻamatala.
136. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus ma le bifidobacterium i le maʻi o le manava o le manava: tali i faʻailoga ma le faʻafesoʻotaʻiga o talaaga o le cytokine. Gastroenterology 2005; 128: 541-51. Vaʻai faʻamatala.
137. Ishikawa H, Akedo I, Umesaki Y, et al. Faʻataʻitaʻia faʻatonutonuina faʻataʻitaʻiga o le aʻafiaga o le bifidobacteria-faʻasusu susu i ulcerative colitis. J Am Coll Nutr 2003; 22: 56-63. Vaʻai faʻamatala.
138. Rastall RA. Siama i le manava: uo ma fili ma pe faʻafefea ona suia le paleni. J Nutr 2004; 134: 2022S-2026S. Vaʻai faʻamatala.
139. Mimura T, Rizzello F, Helwig U, et al. Faʻatasi i aso uma le maualuga inumaga probiotic togafitiga (VSL # 3) mo le faʻamautuina o le faʻamagaloina i le toe tupu poʻo le faʻaaogaina o le ato. Gut 2004; 53: 108-14. Vaʻai faʻamatala.
140. Cremonini F, Di Caro S, Covino M, et al. Aʻafiaga o eseese probiotic sauniuniga on anti-helicobacter pylori togafitiga-fesoʻotaʻiga aʻafiaga: o se tutusa vaega, tolu faʻatauaso, placebo-pulea suesuega. Am J Gastroenterol 2002; 97: 2744-9. Vaʻai faʻamatala.
141. Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis ma Lactobacillus F19 puipuia le faʻatupuina o vailaʻau faʻaleagaina o le Bacteroides i le manava. J Antimicrob Chemother 2003; 52: 308-11. Vaʻai faʻamatala.
142. Kim HJ, Camilleri M, McKinzie S, et al. O se faʻataʻitaʻiga faʻatonutonuina faʻataʻitaʻiina o le probiotic, VSL # 3, i luga ole manava ma faʻailoga i le manava manava-sili ona afaina ai le manava o le manava. Aliment Pharmacol Ther 2003; 17: 895-904. . Vaʻai faʻamatala.
143. Roberfroid MB. Prebiotics ma probiotics: o ni meaʻai meaʻai? Am J Clin Nutr 2000; 71: 1682S-7S. Vaʻai faʻamatala.
144. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy o se togafitiga faʻataʻitaʻi i tagata mamaʻi e maua i le tumau pouchitis: o faʻalua-tauaso, placebo-pulea faʻamasinoga. Gastroenterology 2000; 119: 305-9. Vaʻai faʻamatala.
145. Rautio M, Jousimies-Somer H, Kauma H, et al. E leai se eseesega o le ate ona o le Lactobacillus rhamnosus, e le mafai ona iloa mai le L. rhamnosus strain GG. Clin Infect Dis Dis 1999; 28: 1159-60. Vaʻai faʻamatala.
146. Goldin BR. Soifua Maloloina penefiti. Br J Nutr 1998; 80: S203-7. Vaʻai faʻamatala.
147. Kalima P, Masterton RG, Roddie PH, et al. Siama Lactobacillus rhamnosus i se tamaititi mulimuli ane totoina o ponaivi ponaivi. J Infect 1996; 32: 165-7. Vaʻai faʻamatala.
148. Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli ma siama i le itu i saute o Finelani 1989-1992. Clin Infect Dis Dis 1996; 22: 564-6. Vaʻai faʻamatala.
149. Lewis SJ, Freedman AR. Tusitusiga toe iloilo: o le faʻaaogaina o vailaʻau o le biotherapeutic i le puipuia ma le togafitia o faʻamaʻi gastrointestinal. Aliment Pharmacol Ther 1998; 12: 807-22. Vaʻai faʻamatala.
150. Meydani SN, Ha WK. Aafiaga puipuia o yogurt. Am J Clin Nutr 2000; 71: 861-72. Vaʻai faʻamatala.
151. Isolauri E, Arvola T, Sutas Y, et al. Probiotics i le puleaina o atopic eczema. Clin Exp Allergy 2000; 30: 1604-10. Vaʻai faʻamatala.
152. Korschunov VM, Smeyanov VV, Efimov BA, et al. Faʻaaoga togafitiga o se vailaʻau-puipuia Bifidobacterium sauniuniga i aliʻi faʻaalia i maualuga-inumaga gamma-faʻasusu. J Med Microbiol 1996; 44: 70-4. Vaʻai faʻamatala.
153. Venturi A, Gionchetti P, Rizzello F, et al. Aʻafiaga i luga o le tuufaatasiga o le fecec flora e ala i se fou sauniuniga probiotic: muamua faʻamatalaga i le tausiga togafitiga o tagata mamaʻi ma ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103-8. Vaʻai faʻamatala.
154. Phuapradit P, Varavithya W, Vathanophas K, et al. Faʻaititia o siama rotavirus i tamaiti mauaina bifidobacteria-supplement supplement. J Med Assoc Thai 1999; 82: S43-8. Vaʻai faʻamatala.
155. Hoyos AB. Faʻaititia le tuputupu ae o le necrotizing enterocolitis fesoʻotaʻi ma enteral pulega o Lactobacillus acidophilus ma Bifidobacterium infantis i neonates i se potu tigaina tiga. Int J Infect Dis 1999; 3: 197-202. Vaʻai faʻamatala.
156. Pierce A. O le American Pharmaceutical Association Faʻataʻitaʻiga Taua i Vailaʻau Faʻanatura. Niu Ioka: The Stonesong Press, 1999: 19.
157. Chen RM, Wu JJ, Lee SC, et al. Faʻateleina o le Bifidobacterium o le manava ma le taofiofia o siama coliform faʻatasi ai ma le taumafaina o le yogurt i se taimi puʻupuʻu. J Dairy Sci 1999: 82: 2308-14. Vaʻai faʻamatala.
158. Ha GY, Yang CH, Kim H, Chong Y. Tulaga o sepsis mafua mai i Bifidobacterium longum. J Clin Microbiol 1999; 37: 1227-8. Vaʻai faʻamatala.
159. Colombel JF, Cortot A, Neut C, Romond C. Yoghurt ma le Bifidobacterium longum e faʻaititia ai le erythromycin-gastrointestinal effects. Lancet 1987; 2:43.
160. Hirayama K, Rafter J. O le matafaioi a siama probiotic i le puipuia o le kanesa. Iniseti microbes 2000; 2: 681-6. Vaʻai faʻamatala.
161. Macfarlane GT, Cummings JH. Probiotics ma faʻamalosi tino: e mafai ona faʻatonutonuina gaioiga o siama faiʻai e aoga i le soifua maloloina? BMJ 1999; 318: 999-1003. Vaʻai faʻamatala.
162. Chiang BL, Sheih YH, Wang LH, et al. Faʻamalosia le puipuia e ala i le taumafaina o meaʻai i le probiotic lactic acid bacterium (Bifidobacterium lactis HN019): faʻalelei ma faʻauigaina o tali puipuia mai sela. Eur J Clin Nutr 2000; 54: 849-55. Vaʻai faʻamatala.
163. Lievin V, Peiffer I, Hudault S, et al. Bifidobacterium ituaiga mai le nofo ai pepe tagata manava gastrointestinal microflora faia antimicrobial gaioiga. Gut 2000; 47: 646-52. Vaʻai faʻamatala.
164. Arunachalam K, Gill HS, Chandra RK. Faʻalauteleina o le natura puipuia galuega e ala i taumafa taumafa o Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000; 54: 263-7. Vaʻai faʻamatala.
165. Bouhnik Y, Pochart P, Marteau P, et al. Fecal toe faʻaleleia i tagata o mafai ola bifidobacterium 'aʻafia i fefete susu. Gastroenterology 1992; 102: 875-8. Vaʻai faʻamatala.
166. Saavedra JM, et al. Fafagaina o bifidobacterium bifidum ma streptococcus thermophilus i pepe i le falemai mo le puipuia o le manava tata ma le faamaligiina o rotavirus. Lancet 1994; 344: 1046-9. Vaʻai faʻamatala.
167. Scarpignato C, Rampal P. Puipuiga ma le togafitia o le tagata malaga o le manava tata: O se falemaʻi falemaʻi falemaʻi. Chemotherapy 1995; 41: 48-81. Vaʻai faʻamatala.
168. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic Agents, O se tulaga le amanaʻiaina mo le togafitiga ma le puipuia o filifiliga filifilia o le manava ma siama. JAMA 1996; 275: 870-5. Vaʻai faʻamatala.

Toe iloiloga - 11/25/2020